This old version of Proteopedia is provided for student assignments while the new version is undergoing repairs. Content and edits done in this old version of Proteopedia after March 1, 2026 will eventually be lost when it is retired in about June of 2026.

Apply for new accounts at the new Proteopedia. Your logins will work in both the old and new versions.


2fm2

From Proteopedia

(Difference between revisions)
Jump to: navigation, search
Line 1: Line 1:
-
[[Image:2fm2.gif|left|200px]]
+
{{Seed}}
 +
[[Image:2fm2.png|left|200px]]
<!--
<!--
Line 9: Line 10:
{{STRUCTURE_2fm2| PDB=2fm2 | SCENE= }}
{{STRUCTURE_2fm2| PDB=2fm2 | SCENE= }}
-
'''HCV NS3-4A protease domain complexed with a ketoamide inhibitor, SCH446211'''
+
===HCV NS3-4A protease domain complexed with a ketoamide inhibitor, SCH446211===
-
==Overview==
+
<!--
-
Drug resistance is a major issue in the development and use of specific antiviral therapies. Here we report the isolation and characterization of hepatitis C virus RNA replicons resistant to a novel ketoamide inhibitor of the NS3/4A protease, SCH6 (originally SCH446211). Resistant replicon RNAs were generated by G418 selection in the presence of SCH6 in a dose-dependent fashion, with the emergence of resistance reduced at higher SCH6 concentrations. Sequencing demonstrated remarkable consistency in the mutations conferring SCH6 resistance in genotype 1b replicons derived from two different strains of hepatitis C virus, A156T/A156V and R109K. R109K, a novel mutation not reported previously to cause resistance to NS3/4A inhibitors, conferred moderate resistance only to SCH6. Structural analysis indicated that this reflects unique interactions of SCH6 with P'-side residues in the protease active site. In contrast, A156T conferred high level resistance to SCH6 and a related ketoamide, SCH503034, as well as BILN 2061 and VX-950. Unlike R109K, which had minimal impact on NS3/4A enzymatic function, A156T significantly reduced NS3/4A catalytic efficiency, polyprotein processing, and replicon fitness. However, three separate second-site mutations, P89L, Q86R, and G162R, were capable of partially reversing A156T-associated defects in polyprotein processing and/or replicon fitness, without significantly reducing resistance to the protease inhibitor.
+
The line below this paragraph, {{ABSTRACT_PUBMED_16352601}}, adds the Publication Abstract to the page
 +
(as it appears on PubMed at http://www.pubmed.gov), where 16352601 is the PubMed ID number.
 +
-->
 +
{{ABSTRACT_PUBMED_16352601}}
==About this Structure==
==About this Structure==
Line 40: Line 44:
[[Category: Ketoamide inhibitor]]
[[Category: Ketoamide inhibitor]]
[[Category: Ns3/4a protease]]
[[Category: Ns3/4a protease]]
-
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Sun May 4 04:03:16 2008''
+
 
 +
''Page seeded by [http://oca.weizmann.ac.il/oca OCA ] on Mon Jul 28 14:19:45 2008''

Revision as of 11:19, 28 July 2008

Image:2fm2.png

Template:STRUCTURE 2fm2

HCV NS3-4A protease domain complexed with a ketoamide inhibitor, SCH446211

Template:ABSTRACT PUBMED 16352601

About this Structure

2FM2 is a Single protein structure of sequence from Hepatitis c virus. Full crystallographic information is available from OCA.

Reference

Mutations conferring resistance to SCH6, a novel hepatitis C virus NS3/4A protease inhibitor. Reduced RNA replication fitness and partial rescue by second-site mutations., Yi M, Tong X, Skelton A, Chase R, Chen T, Prongay A, Bogen SL, Saksena AK, Njoroge FG, Veselenak RL, Pyles RB, Bourne N, Malcolm BA, Lemon SM, J Biol Chem. 2006 Mar 24;281(12):8205-15. Epub 2005 Dec 13. PMID:16352601

Page seeded by OCA on Mon Jul 28 14:19:45 2008

Proteopedia Page Contributors and Editors (what is this?)

OCA

Retrieved from "http://52.214.119.220/wiki/index.php/2fm2"
Personal tools